Article

Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunity

2022-09-02

Abstract excerpt

The immune response to SARS-CoV-2 for patients with altered immunity such as hematologic malignancies and autoimmune disease may differ substantially from that in general population. These patients remain at high risk despite wide-spread adoption of vaccination. It is critical to examine the differences at the systems level between the general population and the patients with altered immunity in terms of immunolog...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2dc4e2dc-d50a-51a2-844d-8b53d80c1d05
DOI: 10.1101/2022.08.31.506117

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunityDOI 10.1101/2022.08.31.506117Read

Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patientsSemantic proximity Read

Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individualsSemantic proximity Read

Immunoprecipitation-targeted proteomics assays facilitate rational development of SARS-CoV-2 serological diagnosticsSemantic proximity Read

Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesSemantic proximity Read

A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled bloodSemantic proximity Read

Proteomic analysis of circulating immune cells identifies novel cellular phenotypes associated with COVID-19 severitySemantic proximity Read

Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variantsSemantic proximity Read

Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesSemantic proximity Read

SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individualsSemantic proximity Read

Precise blood proteome profiling in an undiagnosed population with COVID-19Semantic proximity Read

Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity.Semantic proximity Read

Machine-learning-aided multiplexed nanobiosensor for COVID-19 population immunity profilingSemantic proximity Read